Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories

Divis Laboratories

BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 14, 14:03
1047.35
7.05 (0.68%)
VOLUME 11,248
LIVE
NSE
Dec 14, 14:02
1048.45
6.25 (0.6%)
VOLUME 415,129
News on Divis Laboratories
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Divis Laboratories, sell L&T Finance; see 10-15% upside in Amara Raja: Sudarshan Sukhani 

11.49 am | 12 Dec 2017 |  Source: CNBC-TV18

According to Sudarshan Sukhani of s2analytics.com, one may buy Divis Laboratories....

Buy Divis Labs, Bajaj Auto, Tata Chemicals, V-Guard Industries; sell Chennai Petroleum: Sudarshan Sukhani 

9.17 am | 21 Nov 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Divis Laboratories, Bajaj Auto, Tata Chemicals and V-Guard Industries and can sel...

Buy Divis Laboratories, Raymond: Sudarshan Sukhani 

2.01 pm | 20 Nov 2017 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com...

Divis Laboratories rises 2% as Vizag unit get EIR from USFDA

11.29 am | 20 Nov 2017 |  Source: Moneycontrol.com

The company has received an establishment inspection report (EIR) from United States Food & Drug Administration (USFDA) for its Unit-II at Visakhapatn...

News highlights of the day: Honda recalling 900,000 minivans because seats may tip forward

9.23 am | 18 Nov 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

USFDA lifts import alert on Divi's Laboratories unit

11.15 am | 15 Nov 2017 |  Source: PTI

Last week, the company in a regulatory filing had said the US Food and Drug Administration (USFDA) had "closed out" a warning letter issued to the uni...

Here are fundamental trading ideas from SP Tulsian 

9.59 am | 15 Nov 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18's Latha Venkatesh, Anuj Singhal, and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on...

News highlights of the day: RBI Governor Urjit Patel appointed on BIS advisory board

7.17 am | 15 Nov 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Buy Divis Laboratories; target of Rs 1275: Sharekhan

5.24 pm | 13 Nov 2017 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 1275 in its research report dated Novembe...

News Live: Pakistan allows Kulbhushan Jadhav to meet wife

1.50 pm | 10 Nov 2017 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

USFDA withdraws warning letter to Divi's Laboratories unit

10.31 am | 10 Nov 2017 |  Source: PTI

"Divi's Laboratories has been informed by the USFDA that the agency has completed evaluation of the company's corrective actions in response t...

Hold Divi’s Laboratories; target of Rs 1090: ICICI Direct

4.28 pm | 07 Nov 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 1090 in its research report dated November 03, 2017....

Divis Lab down 4%; Edelweiss maintains reduce, rules out growth for next 2-yrs

10.44 am | 03 Nov 2017 |  Source: Moneycontrol.com

The firm has revised its FY19e EPS by 10 percent post current clearance of regulatory issues. It also rule out growth for next 2 years as company is u...

Divis Labs Q2 profit seen down 1% on lower operational income and revenue 

6.18 pm | 30 Oct 2017 |  Source: CNBC-TV18

Revenue may decline due to ongoing USFDA import alert and re-inspection in Q2 of Unit 2....

Buy Divi's Laboratories; target of Rs 1080: Axis Direct

5.37 pm | 09 Oct 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 1080 in its research report dated ...

Hold Divi’s Laboratories; target of Rs 1040: Sharekhan

3.33 pm | 26 Sep 2017 |  Source: Moneycontrol.com

Sharekhan is recommended hold rating on Divi’s Laboratories with a target price of Rs 1040 in its research report dated September 20, 2017....

Hold Divi’s Laboratories; target of Rs 665: ICICI Direct

4.09 pm | 26 Jul 2017 |  Source: Moneycontrol.com

ICICI Direct recommended hold rating on Divi’s Laboratories with a target price of Rs 665 in its research report dated July 24, 2017....

Hold Divi’s Laboratories; target of Rs 740: ICICI Direct

3.55 pm | 11 Jul 2017 |  Source: Moneycontrol.com

ICICI Direct has recommended Hold rating on Divi’s Laboratories with a target price of Rs 740 in its research report dated July 10, 2017....

1 2
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.